Attached files
| file | filename |
|---|---|
| EX-10.30 - EX-10.30 - Civitas Therapeutics, Inc. | d719498dex1030.htm |
| EX-10.26 - EX-10.26 - Civitas Therapeutics, Inc. | d719498dex1026.htm |
| EX-3.2 - EX-3.2 - Civitas Therapeutics, Inc. | d719498dex32.htm |
| EX-10.15 - EX-10.15 - Civitas Therapeutics, Inc. | d719498dex1015.htm |
| EX-10.17 - EX-10.17 - Civitas Therapeutics, Inc. | d719498dex1017.htm |
| EX-10.14 - EX-10.14 - Civitas Therapeutics, Inc. | d719498dex1014.htm |
| EX-4.2 - EX-4.2 - Civitas Therapeutics, Inc. | d719498dex42.htm |
| EX-10.2 - EX-10.2 - Civitas Therapeutics, Inc. | d719498dex102.htm |
| EX-10.16 - EX-10.16 - Civitas Therapeutics, Inc. | d719498dex1016.htm |
| S-1 - S-1 - Civitas Therapeutics, Inc. | d719498ds1.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated May 12, 2014, in the Registration Statement (Form S-1) and related Prospectus of Civitas Therapeutics, Inc. dated August 26, 2014.
/s/ Ernst & Young LLP
Boston, Massachusetts
August 26, 2014